Neurocoaching

Silvia Escribano , Guglielmo Foffani , Fernando de Castro
Madrid: Editorial Alienta

4
2015
ApTOLL: A new therapeutic aptamer for cytoprotection and (re) myelination after multiple sclerosis

Beatriz Fernández‐Gómez , Miguel A Marchena , David Piñeiro , Paula Gómez‐Martín
British Journal of Pharmacology

2
2024
The Importance of Cajal’s and Lorente de Nó’s Neuroscience to the Birth of Cybernetics

Juan Manuel Espinosa-Sanchez , Alex Gomez-Marin , Fernando de Castro
The Neuroscientist 10738584231179932 -10738584231179932

1
2023
Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease

Javier Villadiego , Roberto García-Swinburn , Diego García-González , Rafael Lebrón-Galán
Brain Structure and Function 228 ( 3) 907 -920

1
2023
OBITUARIO: Dr. Juan Vicente Sánchez Andrés

JM Delgado-García , Liset Menéndez de la Prida , Rafael Alonso , Fernando de Castro
Sociedad Española de Ciencias Fisiológicas

2023
2022
Charla-debate: Retos Neurológicos en Clínica e Investigación en España

M González Sánchez , P Rábano Suárez , Fernando de Castro

2019
Human Adult Oligodendrocyte Precursor Cell Biology: The Bottleneck for Effective Pro-remyelinating Therapies for Multiple Sclerosis

Fernando de Castro
Converging Clinical and Engineering Research on Neurorehabilitation II: Proceedings of the 3rd International Conference on NeuroRehabilitation (ICNR2016), October 18-21, 2016, Segovia, Spain 67 -68

2017
Anosmin-1 and Galectin-1 as Laminin Interactors in Nervous System Development and Pathology

Silvia Velasco , Fernando de Castro
Nova Science Publishers Inc., New York (USA). 3 53 -68

2013